331 related articles for article (PubMed ID: 27147285)
1. The Worsening Profile of Alcoholic Hepatitis in the United States.
Nguyen TA; DeShazo JP; Thacker LR; Puri P; Sanyal AJ
Alcohol Clin Exp Res; 2016 Jun; 40(6):1295-303. PubMed ID: 27147285
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
[TBL] [Abstract][Full Text] [Related]
3. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events.
Verma S; Ajudia K; Mendler M; Redeker A
Dig Dis Sci; 2006 Sep; 51(9):1637-43. PubMed ID: 16927139
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic hepatitis: Prognosis and treatment.
Casanova J; Bataller R
Gastroenterol Hepatol; 2014 Apr; 37(4):262-8. PubMed ID: 24656653
[TBL] [Abstract][Full Text] [Related]
6. Time course of compromised urea synthesis in patients with alcoholic hepatitis.
Glavind E; Aagaard NK; Gronbaek H; Orntoft NW; Vilstrup H; Thomsen KL
Scand J Gastroenterol; 2018 May; 53(5):592-597. PubMed ID: 29113530
[TBL] [Abstract][Full Text] [Related]
7. A prognostic evaluation and management of alcoholic hepatitis.
Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
[TBL] [Abstract][Full Text] [Related]
8. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
[TBL] [Abstract][Full Text] [Related]
9. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and treatment of patients with acute alcoholic hepatitis.
Papastergiou V; Burroughs AK; Tsochatzis EA
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):471-86. PubMed ID: 24716632
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.
Pang JX; Ross E; Borman MA; Zimmer S; Kaplan GG; Heitman SJ; Swain MG; Burak K; Quan H; Myers RP
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):131-8. PubMed ID: 25855876
[TBL] [Abstract][Full Text] [Related]
12. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
[TBL] [Abstract][Full Text] [Related]
13. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
Mathurin P; Louvet A; Duhamel A; Nahon P; Carbonell N; Boursier J; Anty R; Diaz E; Thabut D; Moirand R; Lebrec D; Moreno C; Talbodec N; Paupard T; Naveau S; Silvain C; Pageaux GP; Sobesky R; Canva-Delcambre V; Dharancy S; Salleron J; Dao T
JAMA; 2013 Sep; 310(10):1033-41. PubMed ID: 24026598
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
15. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
Arab JP; Díaz LA; Baeza N; Idalsoaga F; Fuentes-López E; Arnold J; Ramírez CA; Morales-Arraez D; Ventura-Cots M; Alvarado-Tapias E; Zhang W; Clark V; Simonetto D; Ahn JC; Buryska S; Mehta TI; Stefanescu H; Horhat A; Bumbu A; Dunn W; Attar B; Agrawal R; Haque ZS; Majeed M; Cabezas J; García-Carrera I; Parker R; Cuyàs B; Poca M; Soriano G; Sarin SK; Maiwall R; Jalal PK; Abdulsada S; Higuera-de la Tijera MF; Kulkarni AV; Rao PN; Guerra Salazar P; Skladaný L; Bystrianska N; Prado V; Clemente-Sanchez A; Rincón D; Haider T; Chacko KR; Cairo F; de Sousa Coelho M; Romero GA; Pollarsky FD; Restrepo JC; Castro-Sanchez S; Toro LG; Yaquich P; Mendizabal M; Garrido ML; Narvaez A; Bessone F; Marcelo JS; Piombino D; Dirchwolf M; Arancibia JP; Altamirano J; Kim W; Araujo RC; Duarte-Rojo A; Vargas V; Rautou PE; Issoufaly T; Zamarripa F; Torre A; Lucey MR; Mathurin P; Louvet A; García-Tsao G; González JA; Verna E; Brown RS; Roblero JP; Abraldes JG; Arrese M; Shah VH; Kamath PS; Singal AK; Bataller R
J Hepatol; 2021 Nov; 75(5):1026-1033. PubMed ID: 34166722
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic hepatitis.
Damgaard Sandahl T
Dan Med J; 2014 Oct; 61(10):B4755. PubMed ID: 25283626
[TBL] [Abstract][Full Text] [Related]
17. Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data.
Pang JX; Ross E; Borman MA; Zimmer S; Kaplan GG; Heitman SJ; Swain MG; Burak KW; Quan H; Myers RP
BMC Gastroenterol; 2015 Sep; 15():116. PubMed ID: 26362871
[TBL] [Abstract][Full Text] [Related]
18. New paradigms in management of alcoholic hepatitis: a review.
Sidhu SS; Goyal O; Kishore H; Sidhu S
Hepatol Int; 2017 May; 11(3):255-267. PubMed ID: 28247264
[TBL] [Abstract][Full Text] [Related]
19. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
Trépo E; Goossens N; Fujiwara N; Song WM; Colaprico A; Marot A; Spahr L; Demetter P; Sempoux C; Im GY; Saldarriaga J; Gustot T; Devière J; Thung SN; Minsart C; Sersté T; Bontempi G; Abdelrahman K; Henrion J; Degré D; Lucidi V; Rubbia-Brandt L; Nair VD; Moreno C; Deltenre P; Hoshida Y; Franchimont D
Gastroenterology; 2018 Mar; 154(4):965-975. PubMed ID: 29158192
[TBL] [Abstract][Full Text] [Related]
20. Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.
Mitchell MC; Friedman LS; McClain CJ
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):5-12. PubMed ID: 27979049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
